Dasatinib-Related Chylothorax
Dasatinib is a potent second-generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The most common adverse event associated with dasatinib therapy is fluid retention, including pleural effusion. Dasatinib-related chylothorax has rarely been reported. The clinical manife...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Galenos Publishing
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439910/ |